Concepedia

Shujing Zhang

SZ

Statistics

Publications

2

Citations

27

H-Index

2

Active since

2023

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Shujing Zhang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacoeconomics, pharmacoeconomic modeling, and healthcare cost analysis.

ORCID

Publications per year

2023–2023

2

Publications

2

Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States

Shujing Zhang, Arielle G. Bensimon, Ruifeng Xu et al. · Advances in Therapy · 2023 · 16 citations · Full text

, , +17

Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland

Andrea Favre-Bulle, Goran Benčina, Shujing Zhang et al. · Journal of Medical Economics · 2023 · 11 citations · Full text

, , +17

1–2 of 2